Latest News and Press Releases
Want to stay updated on the latest news?
-
IN8bio to Showcase Next-Generation T Cell Engager Platform and New Clinical Data at Upcoming R&D Day and Medical Conferences
-
BRISBANE, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- Annexon, Inc. (Nasdaq: ANNX), a biopharmaceutical company advancing the next generation platform of targeted immunotherapies aimed at...
-
ATLANTA and BOSTON, May 06, 2026 (GLOBE NEWSWIRE) -- ABLi Therapeutics (“ABLi”), a biotechnology company developing therapeutics to address diseases that arise from activation of Abelson Tyrosine...
-
WEST HOLLYWOOD, Calif., May 06, 2026 (GLOBE NEWSWIRE) -- VisionWave Holdings, Inc. (Nasdaq: VWAV) (“VisionWave” or the “Company”), a defense and advanced sensing technology company developing...
-
LOS ANGELES, May 06, 2026 (GLOBE NEWSWIRE) -- TravelTech Breakthrough, a leading independent market intelligence organization that evaluates and recognizes standout travel technology companies...
-
Cloud Software Group deploys Kahuna AI to modernize support, improving resolution speed, efficiency, and customer outcomes across its software portfolio.
-
DALLAS, May 06, 2026 (GLOBE NEWSWIRE) -- ChronoScale Corporation (NASDAQ: CHRN), an accelerated compute platform purpose-built to support demanding artificial intelligence workloads, today announced...
-
VANCOUVER, British Columbia, May 06, 2026 (GLOBE NEWSWIRE) -- Canfor Corporation (the “Company” or “Canfor”) (TSX: CFP) today reported its first quarter of 2026 results: Overview. For the first...
-
Kaskela Law is reviewing the Global Business Travel Group, Inc. (NYSE: GBTG) (“Amex GBT”) shareholder buyout to assess its fairness to GBTG shareholders.
-
FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY...